WS Management Lllp Sells 30,000 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

WS Management Lllp cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 23.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 100,000 shares of the exchange traded fund’s stock after selling 30,000 shares during the quarter. SPDR S&P Biotech ETF accounts for approximately 0.8% of WS Management Lllp’s holdings, making the stock its 18th largest position. WS Management Lllp owned approximately 0.13% of SPDR S&P Biotech ETF worth $9,006,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Demars Financial Group LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $280,309,000. BlueCrest Capital Management Ltd bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $138,051,000. Mirae Asset Securities USA Inc. lifted its position in SPDR S&P Biotech ETF by 66.7% in the 4th quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock valued at $135,090,000 after acquiring an additional 600,000 shares in the last quarter. Bessemer Group Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 5.7% during the 4th quarter. Bessemer Group Inc. now owns 1,376,834 shares of the exchange traded fund’s stock valued at $123,997,000 after buying an additional 73,866 shares during the period. Finally, RA Capital Management L.P. bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $110,615,000.

SPDR S&P Biotech ETF Price Performance

NYSEARCA XBI opened at $79.72 on Tuesday. The business’s fifty day moving average price is $79.73 and its 200-day moving average price is $88.33. The stock has a market capitalization of $5.02 billion, a price-to-earnings ratio of 11.47 and a beta of 0.91. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.